• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞、凝血和纤溶的激活增强,并与肾抗中性粒细胞胞浆抗体相关性血管炎相关。

Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis.

机构信息

Department of Medicine, Vaasa Central Hospital, Vaasa, Finland.

Division of Nephrology, Department of Medicine, Helsinki University Hospital, Helsinki, Finland.

出版信息

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i53-9. doi: 10.1093/ndt/gfu379. Epub 2014 Dec 18.

DOI:10.1093/ndt/gfu379
PMID:25523447
Abstract

BACKGROUND

While the incidence of thromboembolism in anti-neutrophil cytoplasmic antibodies-associated vasculitis (AAV) is high, the coagulation and fibrinolysis profile in AAV patients remains poorly characterized. We aimed at studying this profile in association with vasculitis activity and renal function.

METHODS

This prospective study included 21 AAV patients with renal disease and 40 controls with other chronic kidney disease. Platelet count, antithrombin, FVIII : C, von Willebrand factor (VWF) activities (VWF : RCo) and antigen (VWF : Ag), fibrinogen, prothrombin fragments (F1 + 2), fibrin degradation product d-dimer and the presence of antiphospholipid antibodies were measured during the active and remission states of the AAV and at the baseline in controls. Occurrence of thromboembolic events was recorded.

RESULTS

F1 + 2 was 2.6-fold and D-dimer was 5-fold higher during the active AAV than its remission (median 563 versus 212 pM and 3.0 versus 0.6 mg/L, P = 0.001 for both). FVIII : C (median 228%), VWF : RCo (198%) and VWF : Ag (222%) were the highest among the patients with active AAV and remained elevated also under remission. In active AAV, both F1 + 2 and d-dimer clearly associated with impaired renal function (r = -0.67, P = 0.001 and r = -0.66, P = 0.001). In AAV patients, two thromboembolic events occurred during the follow-up.

CONCLUSIONS

In active renal AAV, thrombin formation and especially fibrin turnover prevail compared both with remission and other kidney diseases. Overall, AAV is characterized by an enhanced coagulation, especially FVIII activity, which continues partly in remission.

摘要

背景

尽管抗中性粒细胞胞浆抗体相关性血管炎(AAV)患者的血栓栓塞发生率较高,但 AAV 患者的凝血和纤溶谱仍未得到充分描述。我们旨在研究该谱与血管炎活动和肾功能的关系。

方法

本前瞻性研究纳入了 21 例伴有肾脏疾病的 AAV 患者和 40 例其他慢性肾脏病的对照者。在 AAV 的活动期和缓解期以及对照组的基线时,测量血小板计数、抗凝血酶、FVIII:C、血管性血友病因子(VWF)活性(VWF:RCo)和抗原(VWF:Ag)、纤维蛋白原、凝血酶原片段(F1+2)、纤维蛋白降解产物 D-二聚体和抗磷脂抗体的存在情况。记录血栓栓塞事件的发生情况。

结果

与缓解期相比,AAV 活动期的 F1+2 增加了 2.6 倍,D-二聚体增加了 5 倍(中位数 563 对 212 pM 和 3.0 对 0.6 mg/L,均 P=0.001)。FVIII:C(中位数 228%)、VWF:RCo(198%)和 VWF:Ag(222%)在活动期 AAV 患者中最高,在缓解期仍处于升高状态。在活动期 AAV 中,F1+2 和 D-二聚体均与肾功能不全明显相关(r=-0.67,P=0.001 和 r=-0.66,P=0.001)。在 AAV 患者中,在随访期间发生了 2 例血栓栓塞事件。

结论

在活动期肾 AAV 中,与缓解期和其他肾脏疾病相比,凝血酶的形成,尤其是纤维蛋白的转化更为明显。总的来说,AAV 的特点是凝血增强,尤其是 FVIII 活性,部分在缓解期仍持续存在。

相似文献

1
Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis.内皮细胞、凝血和纤溶的激活增强,并与肾抗中性粒细胞胞浆抗体相关性血管炎相关。
Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i53-9. doi: 10.1093/ndt/gfu379. Epub 2014 Dec 18.
2
Coagulation and fibrinolysis index profile in patients with ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关血管炎患者的凝血和纤维蛋白溶解指标概况
PLoS One. 2014 May 19;9(5):e97843. doi: 10.1371/journal.pone.0097843. eCollection 2014.
3
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable.伴有抗中性粒细胞胞浆抗体相关性血管炎缓解的患者存在高凝状态。
J Rheumatol. 2013 Dec;40(12):2042-6. doi: 10.3899/jrheum.130200. Epub 2013 Oct 15.
4
Blood coagulation system in patients with chronic kidney disease: a prospective observational study.慢性肾脏病患者的血液凝固系统:一项前瞻性观察研究。
BMJ Open. 2017 Jun 1;7(5):e014294. doi: 10.1136/bmjopen-2016-014294.
5
Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis.抗纤溶酶原抗体损害纤维蛋白溶解,并与 ANCA 相关性血管炎的肾组织学相关。
J Am Soc Nephrol. 2010 Dec;21(12):2169-79. doi: 10.1681/ASN.2010030274. Epub 2010 Sep 16.
6
Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.在诱导缓解后仍为胞质型抗中性粒细胞胞质抗体阳性的新诊断的蛋白酶3抗中性粒细胞胞质抗体相关血管炎患者中,延长与标准硫唑嘌呤维持治疗的比较:一项随机临床试验
Nephrol Dial Transplant. 2016 Sep;31(9):1453-9. doi: 10.1093/ndt/gfw211. Epub 2016 May 30.
7
Sphingosine-1-phosphate in anti-neutrophil cytoplasmic antibody-associated vasculitis: coagulation-related clinical indicators and complications.鞘氨醇-1-磷酸在抗中性粒细胞胞质抗体相关性血管炎中的作用:与凝血相关的临床指标和并发症。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20200157.
8
Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.中性粒细胞胞外诱捕网在抗中性粒细胞胞浆抗体相关性血管炎坏死性病变中的形成和紊乱降解。
Am J Pathol. 2019 Apr;189(4):839-846. doi: 10.1016/j.ajpath.2019.01.007. Epub 2019 Jan 21.
9
Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.在小血管血管炎患者的循环中,中性粒细胞胞外诱捕网残余物的水平增加,但在缓解期与抗中性粒细胞胞浆抗体呈负相关。
Rheumatology (Oxford). 2015 Nov;54(11):2085-94. doi: 10.1093/rheumatology/kev217. Epub 2015 Jul 12.
10
Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.尿液可溶性 CD163 和单核细胞趋化蛋白-1 识别抗中性粒细胞胞浆抗体相关性血管炎中的隐匿性肾复发。
Nephrol Dial Transplant. 2020 Feb 1;35(2):283-291. doi: 10.1093/ndt/gfy300.

引用本文的文献

1
Assessment of cardiovascular risk in patients with ANCA-associated vasculitis: A systematic review and meta-analysis.抗中性粒细胞胞浆抗体相关血管炎患者心血管风险评估:一项系统评价与荟萃分析。
Int J Cardiol Cardiovasc Risk Prev. 2024 Sep 25;23:200334. doi: 10.1016/j.ijcrp.2024.200334. eCollection 2024 Dec.
2
Characteristic changes in the mRNA expression profile of plasma exosomes from patients with MPO-ANCA-associated vasculitis and its possible correlations with pathogenesis.血浆外泌体中 MPO-ANCA 相关性血管炎患者 mRNA 表达谱的特征变化及其与发病机制的可能相关性。
Clin Exp Med. 2024 Sep 17;24(1):222. doi: 10.1007/s10238-024-01457-2.
3
A systematic review and meta-analysis of the association between the D-dimer and rheumatic diseases.
D-二聚体与风湿性疾病关联的系统评价和荟萃分析。
Immun Inflamm Dis. 2024 Jul;12(7):e1349. doi: 10.1002/iid3.1349.
4
Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.血管炎中的血栓形成:病因、病理生理学及治疗的最新综述
Heliyon. 2024 May 1;10(12):e30615. doi: 10.1016/j.heliyon.2024.e30615. eCollection 2024 Jun 30.
5
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis.内源性凝血途径在抗中性粒细胞胞浆抗体相关性血管炎导致的高凝状态中起主要作用。
Blood Adv. 2024 Mar 12;8(5):1295-1304. doi: 10.1182/bloodadvances.2023011937.
6
The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score.血管性血友病因子抗原反映青少年皮肌炎疾病活动评分。
Biomedicines. 2023 Feb 14;11(2):552. doi: 10.3390/biomedicines11020552.
7
Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment.自身免疫性风湿病中的神经酰胺:饮食作为抗神经酰胺治疗的现有证据和治疗考虑因素。
Nutrients. 2023 Jan 2;15(1):229. doi: 10.3390/nu15010229.
8
Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China.抗中性粒细胞胞质抗体相关性血管炎(AAV)不良预后的预测因素:中国单中心住院患者的前瞻性研究。
Clin Exp Med. 2023 Aug;23(4):1331-1343. doi: 10.1007/s10238-022-00915-z. Epub 2022 Oct 16.
9
Urinary extracellular vesicles carry multiple activators and regulators of coagulation.尿细胞外囊泡携带多种凝血激活剂和调节剂。
Front Cell Dev Biol. 2022 Sep 7;10:967482. doi: 10.3389/fcell.2022.967482. eCollection 2022.
10
Management of coagulation disorders in severe inflammation.严重炎症中凝血障碍的管理
Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000238. eCollection 2019 Jun.